Discover 754 paid clinical trials in Toledo, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 754
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
for
Aortic Valve Insufficiency, Aortic Valve Stenosis
Location: Detroit MI, Cleveland OH, Cincinnati OH, Pittsburgh PA,
Sponsor: Edwards Lifesciences
Sex: All
Age: 0+
Code: NCT05172973
Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: Detroit MI, Cleveland OH, Grand Rapids MI, Carmel IN,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136650
Phase3, Recruiting
Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)
for
Sickle Cell Trait
Location: Detroit MI, Columbus OH, Indianapolis IN, Wilmington DE,
Sponsor: National Alliance for Sickle Cell Centers
Location: Detroit MI, Columbus OH, London, Toronto, Fairfax VA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT05797168
Phase1, Phase2, Recruiting
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
for
Relapsed AL Amyloidosis, Refractory AL Amyloidosis,
Location: Detroit MI, Cleveland OH, Toronto, St Louis MO,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07081646
Phase1, Phase2, Recruiting
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
for
Breast Cancer
Location: Detroit MI, Cleveland OH, Cincinnati OH, Chicago IL,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06103864
Phase3, Recruiting
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
for
Primary Biliary Cholangitis
Location: Detroit MI, Cleveland OH, Columbus OH, Pittsburgh PA,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT06051617
Phase3, Recruiting
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod